Dr. Percent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22395 Edgewater Dr
Port Charlotte, FL 33980Phone+1 941-766-7222Fax+1 941-766-0970
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of Alabama Medical CenterResidency, Internal Medicine, 2002 - 2005
- Louisiana State University School of Medicine in New OrleansClass of 2002
Certifications & Licensure
- FL State Medical License 2008 - 2026
- AL State Medical License 2004 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Start of enrollment: 2015 Apr 29
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 1 citationsPhase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.David S Hong, Federico Cappuzzo, Byoung Chul Cho, Afshin Dowlati, Maen Hussein
Lung Cancer. 2024-04-01 - 36 citationsTelaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent
Clinical Cancer Research. 2022-08-02 - 16 citationsPhase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff
Clinical Cancer Research. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: